Peter Siegl

Peter Siegl

UNVERIFIED PROFILE

Are you Peter Siegl?   Register this Author

Register author
Peter Siegl

Peter Siegl

Publications by authors named "Peter Siegl"

Are you Peter Siegl?   Register this Author

12Publications

1056Reads

8Profile Views

Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity.

Pharmacol Ther 2013 Jun 15;138(3):470-84. Epub 2013 Mar 15.

Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2013.03.005DOI Listing
June 2013

Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.

J Pharmacol Toxicol Methods 2011 Jul-Aug;64(1):7-15. Epub 2011 Jun 12.

Global Discovery Sciences Support, Discovery & Preclinical Sciences, Merck Research Laboratories, 33 Avenue Louis Pasteur, MS: BMB 6-101, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10568719110024
Publisher Site
http://dx.doi.org/10.1016/j.vascn.2011.05.006DOI Listing
February 2012

New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age.

J Pharmacol Toxicol Methods 2004 May-Jun;49(3):153-8

Safety Assessment U.S., Development, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S105687190400027
Publisher Site
http://dx.doi.org/10.1016/j.vascn.2004.03.007DOI Listing
December 2004